Holdings (32)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.89734304% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 7.11797565% |
| Cipla Ltd. | Healthcare | Equity | 6.91029404% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 6.59514134% |
| Lupin Ltd. | Healthcare | Equity | 6.19759059% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 5.85560221% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.48281942% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.15008122% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | Equity | 4.12749938% |
| Suven Pharmaceuticals Ltd. | Healthcare | Equity | 3.95051254% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 19.17% | 18.57% | 24.91% | 27.87% |
| Category Average | 16.68% | 17.78% | 22.58% | NA% |
| Rank Within Category | 6.00% | 7.00% | 2.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 0.61%
Inclusive of GST
Exit load
Exit load of 1% if redeemed within 1 year.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Fund management
Education
B.Com, C.A.
Experience
Prior to joining the Mirae asset MF, he was associated with SBI capital markets.